Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)

Loading page…

Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) · mywealthgrid

About

Sree Rayalaseema Hi-Strength Hypo Limited manufactures commodity chemicals serving industrial and domestic markets. With a market cap of ₹854.07 Cr and quarterly revenues between ₹141–211 Cr, it operates as a mid-cap producer in the Materials sector.

Face value: ₹10

Market cap

₹935 Cr

P/E

10.2×

P/B

1.0×

Dividend yield

1.1%

ROE

9.5%

ROCE

13.2%

Debt / equity

OPM

13.3%

EPS (TTM)

₹53.5

Book value

₹565.9

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Margin volatility: operating margins ranged from 8.2% (Mar 2026) to 14.8% (Sep 2025), indicating exposure to commodity input costs or pricing pressures. Verify hedging strategies and customer concentration.
Seasonal revenue swings: quarterly revenues vary ₹141–211 Cr with apparent peaks in Jun/Sep and troughs in Dec/Mar. Verify whether FY2027 sustains the Jun 2026 level of ₹210.95 Cr.
Stock performance disconnect: 1-year return of -17.06% despite 9.3x PE and 9.54% ROE suggests investor concerns. Verify analyst coverage, competitive positioning, and sector trends.
Tight free float: promoter holding of 61.84% with minimal FII (0.06%) and DII (0.05%) may constrain liquidity. Verify traded volume and capital-market accessibility.

Generated analysis · source review pending

Growth drivers

Jun 2026 revenue of ₹210.95 Cr is highest in recent quarters; verify if structural recovery or seasonal uplift to assess runrate sustainability.
Operating margins sustained at 14%+ in Sep (14.8%), Dec (14.37%), and Jun (14.17%); if margins hold, earnings scale proportionally with volume growth.
Annual dividends distributed consistently since 2021, reflecting stable cash generation; verify capex intensity and reinvestment capacity.

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹543.6-5.5%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 81×
+High promoter holding of 61.8% with no pledge

Cons

−Low return on equity of 10% (3-yr avg)
−Revenue shrank over the last 5 years (-6% a year)
−Low dividend payout of 11.2% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

59/100

Business quality: 55
Growth: 29
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Deepak Fertilizers And Petrochemicals Corporation LimitedDEEPAKFERTDEEPAKFERT	₹16,417 Cr	₹21,903 Cr	₹12,104 Cr	₹2,016 Cr	14.6%	₹984 Cr	6.4%	12.6%	11.3%	55
Tata Chemicals LimitedTATACHEMTATACHEM	₹15,487 Cr	₹23,488 Cr	₹15,120 Cr	₹1,711 Cr	12.4%	₹-2,165 Cr	-11.8%	2.9%	-8.9%	113
Gujarat Narmada Valley Fertilizers And Chemicals LimitedGNFCGNFC	₹8,655 Cr	₹8,655 Cr	₹8,410 Cr	₹1,241 Cr	11.3%	₹1,037 Cr	10.4%	10.6%	9.1%	81
TANFAC Industries LtdTANFACINDTANFACIND	₹6,909 Cr	₹7,002 Cr	₹711 Cr	₹112 Cr	15.8%	₹70 Cr	9.9%	27.7%	20.5%	112
Gujarat Alkalies And Chemicals LimitedGUJALKALIGUJALKALI	₹4,430 Cr	₹4,998 Cr	₹4,498 Cr	₹510 Cr	9.3%	₹66 Cr	-0.1%	1.6%	-0%	25
Grauer & Weil India LimitedGRAUWEILGRAUWEIL	₹3,709 Cr	₹3,717 Cr	₹1,134 Cr	₹188 Cr	16.6%	₹69 Cr	13.9%	23%	18%	72
Ghcl LimitedGHCLGHCL	₹3,700 Cr	₹3,762 Cr	₹3,064 Cr	₹689 Cr	22.5%	₹472 Cr	15.4%	17%	13.4%	126
J.g.chemicals LimitedJGCHEMJGCHEM	₹2,392 Cr	₹2,399 Cr	₹1,071 Cr	₹96 Cr	8.4%	₹75 Cr	7.1%	18.2%	13.3%	101
Thirumalai Chemicals LimitedTIRUMALCHMTIRUMALCHM	₹1,764 Cr	₹3,857 Cr	₹1,832 Cr	₹20 Cr	-2%	₹-152 Cr	-9.7%	-3.3%	-12.3%	14
Ig Petrochemicals LimitedIGPLIGPL	₹1,754 Cr	₹2,110 Cr	₹2,073 Cr	₹207 Cr	4.9%	₹82 Cr	0.1%	3.2%	0.2%	23
Indo Borax & Chemicals LimitedINDOBORAXINDOBORAX	₹1,507 Cr	₹1,507 Cr	₹232 Cr	₹52 Cr	20.5%	₹56 Cr	23.3%	15.5%	15.1%	110
Innovassynth Technologies (India) LtdINOVSYNTHINOVSYNTH	₹1,462 Cr	₹1,466 Cr	₹0 Cr	₹-0 Cr	—	₹-5 Cr	—	-1.1%	-12%	—

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3,63,46,185	1,64,28,771	689	911	1,267	1,650	866	638	667
COGS	2,21,11,274	90,61,877	437	632	927	1,204	566	357	333
Gross profit	1,42,34,912	73,66,894	253	279	341	446	300	281	333
	1,00,00,754	52,54,976	152	149	192	268	190	189	245
	42,34,158	21,11,918	100	130	149	178	111	92	88
OPM %	11.7%	12.9%	14.6%	14.3%	11.7%	10.8%	12.8%	14.4%	13.3%
Depreciation	9,71,684	10,35,142	50	51	19	19	11	7	7
Interest	9,35,265	2,49,491	9	5	3	2	4	2	2
	3,52,668	36,770	4	7	11	34	11	36	41
Profit before tax	—	—	45	81	137	190	107	119	121
Tax	6,78,831	-9,207	8	20	34	36	28	32	31
Tax %	—	—	16.6%	25.1%	25%	19%	26.4%	26.6%	25.4%
	25,04,985	8,73,362	38	61	103	154	79	87	90
PAT margin %	6.9%	5.3%	5.5%	6.7%	8.1%	9.4%	9.1%	13.7%	13.5%
EPS (₹)	17	5.9	22.1	35.3	59.9	89.9	46	51	53.2
EPS adjusted (₹)	—	—	22.1	35.3	59.9	89.9	46	51	52.5
	8.8%	25.3%	11.3%	8.5%	5.8%	4.5%	6.5%	5.9%	5.6%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	17	17	17	17	17	17	17
Reserves	294	371	553	734	783	902	954
Minority interest	—	0	0	0	0	14	13
	40	61	19	12	8	14	0
	94	70	199	160	101	122	131
Total equity & liabilities	445	519	788	923	909	1,071	1,115
	127	110	130	102	119	129	87
CWIP	3	0	0	14	—	0	0
Investments	18	74	164	216	261	357	351
	296	334	494	591	529	585	677
Total assets	445	519	788	923	909	1,071	1,115

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2025 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Chemicals	623.27	78.77	1,023.37	136.86	886.51	8.89
Unallocated	39.47	39.47

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	44.8%	36.6%	30.6%	26.9%	27%	34.7%	44%	50%
EBITDA margin %	12.9%	14.6%	14.3%	11.7%	10.8%	12.8%	14.4%	13.3%
EBIT margin %	6.6%	7.3%	8.8%	10.2%	9.6%	11.5%	13.3%	12.2%
PAT margin %	5.3%	5.5%	6.7%	8.1%	9.4%	9.1%	13.7%	13.5%
Working capital
Receivable days	—	43	39	38	33	45	59	46
Inventory days	—	31	23	57	38	20	41	55
Payable days	—	—	7	30	22	8	15	13
NWC days	—	—	55	64	50	57	85	88
Leverage
Current ratio	—	2.15	2.65	2.35	3.66	10.56	8.99	10.51
Debt to EBITDA	—	0.39	0.47	0.13	0.07	0.07	0.16	0
Debt to equity	—	0.13	0.16	0.03	0.02	0.01	0.02	0
Interest coverage	4.5	6.2	15.8	43.7	94.8	30.7	62.7	81
Asset turnover	—	1.55	1.76	1.61	1.79	0.95	0.6	0.6
Return ratios
Return on assets %	—	8.5%	11.7%	13%	16.7%	8.7%	8.2%	8.1%
Return on capital employed %	—	16.4%	23.6%	28.5%	28.6%	15%	13.3%	13.2%
Return on equity %	—	12.2%	15.6%	18%	20.5%	9.9%	9.5%	9.3%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	62.09%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%	61.84%
	0.63%	0.65%	0.57%	0.56%	0.14%	0.08%	0.14%	0.12%	0.06%	0.06%	0.06%	0.06%
	0.03%	0.03%	0.03%	0.05%	0.03%	0.03%	0.04%	0.05%	0.05%	0.05%	0.05%	0.05%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	37.25%	37.48%	37.56%	37.55%	37.99%	38.05%	37.98%	37.99%	38.05%	38.05%	38.05%	38.05%
No. of shareholders	—	—	—	—	—	—	—	—	43,085	42,527	41,806	40,125

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Sree Rayalaseema Hi-Strength Hypo Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

8 announcementsExport CSV

28 Sept 2026, 5:26 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

28 Sept 2026, 11:34 amCompany Update

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in Directorate PDF

7 Sept 2026, 5:40 pmCompany Update

Submission Of Report Under Special Window

General PDF

5 Sept 2026, 6:00 pmAGM/EGM

Sree Rayalaseema Hi-Strength Hypo Ltd - 532842 - Notice Of 21St Annual General Meeting

AGM PDF

5 Sept 2026, 5:52 pmCompany Update

Intimation With Weblink Of 21St Annual Report

General PDF

5 Sept 2026, 12:51 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

4 Sept 2026, 12:15 pmOthers

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Reporting (BRSR) PDF

4 Sept 2026, 12:10 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

Date	Category	Subject	Filing
28 Sept 2026, 5:26 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
28 Sept 2026, 11:34 am	Company Update Change in Directorate	Announcement under Regulation 30 (LODR)-Change in Directorate

Loading announcements…

Ratio	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	44.8%	36.6%	30.6%	26.9%	27%	34.7%	44%	50%
EBITDA margin %	12.9%	14.6%	14.3%	11.7%	10.8%	12.8%	14.4%	13.3%
EBIT margin %	6.6%	7.3%	8.8%	10.2%	9.6%	11.5%	13.3%	12.2%
PAT margin %	5.3%	5.5%	6.7%	8.1%	9.4%	9.1%	13.7%	13.5%
Working capital
Receivable days	—	43	39	38	33	45	59	46
Inventory days	—	31	23	57	38	20	41	55
Payable days	—	—	7	30	22	8	15	13
NWC days	—	—	55	64	50	57	85	88
Leverage
Current ratio	—	2.15	2.65	2.35	3.66	10.56	8.99	10.51
Debt to EBITDA	—	0.39	0.47	0.13	0.07	0.07	0.16	0
Debt to equity	—	0.13	0.16	0.03	0.02	0.01	0.02	0
Interest coverage	4.5	6.2	15.8	43.7	94.8	30.7	62.7	81
Asset turnover	—	1.55	1.76	1.61	1.79	0.95	0.6	0.6
Return ratios
Return on assets %	—	8.5%	11.7%	13%	16.7%	8.7%	8.2%	8.1%
Return on capital employed %	—	16.4%	23.6%	28.5%	28.6%	15%	13.3%	13.2%
Return on equity %	—	12.2%	15.6%	18%	20.5%	9.9%	9.5%	9.3%

2 deals · 28 Jun 2023 – 28 Jun 2023

Date	Client	Type	Venue	Side	Quantity	Price	Value
28 Jun 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	87,803	₹706.12	₹6.20 Cr
28 Jun 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	87,803	₹705.82	₹6.20 Cr

1–2 of 2

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

₹ Cr	Mar 2016	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	21,12,950	-7,55,181	99	71	60	141	139	65	39
	-9,45,523	-1,31,917	-38	-115	-1	-112	-133	-8	37
	-11,98,705	10,66,259	-22	10	-51	-17	-17	-17	-11
Net cash flow	-31,279	1,79,161	40	-35	7	13	-12	40	65
Free cash flow	—	—	91	50	45	132	119	63	33
CFO / Operating profit %	49.9%	-35.8%	98.8%	54.2%	40.2%	79.6%	125.4%	70.8%	44.3%

Sree Rayalaseema Hi-Strength Hypo Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

13

1

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Chemicals · revenue

Sree Rayalaseema Hi-Strength Hypo Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Ratio timeline

Announcements

Quarterly record

Annual reports

Dividends13

Board meetings1

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Chemicals · revenue

13

1